DNA Interactions of Two Clinical Camptothecin Drugs Stabilize Their Active Lactone Forms
Authors:
- 12 March 1998
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 120 (12) , 2979-2980
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Alteration of DNA Primary Structure by DNA Topoisomerase I. Isolation of the Covalent Topoisomerase I−DNA Binary Complex in Enzymatically Competent FormJournal of the American Chemical Society, 1996
- Interaction of an alkylating camptothecin derivative with a DNA base at topoisomerase I-DNA cleavage sites.Proceedings of the National Academy of Sciences, 1995
- DNA topoisomerase I and II in cancer chemotherapy: update and perspectivesCancer Chemotherapy and Pharmacology, 1993
- A kinetic and Mechanistic Study of the Hydrolysis of Camptothecin and Some AnaloguesJournal of Pharmaceutical Sciences, 1992
- Intercalative drug binding to DNACurrent Opinion in Structural Biology, 1992
- On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complexBiochemistry, 1989
- Modification of the hydroxylactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activityJournal of Medicinal Chemistry, 1989
- Additions and Corrections-Synthesis and Antiviral Activity of Various 3'-Azido, 3'-Amino, 2',3'-Unsaturated, and 2',3'-Dideoxy Analogues of Pyrimidine Deoxyribonucleosides against RetrovirusesJournal of Medicinal Chemistry, 1987
- Synthesis and structure-activity relationships of 1-substituted 4-(1,2-diphenylethyl)piperazine derivatives having narcotic agonist and antagonist activityJournal of Medicinal Chemistry, 1987
- Interactions of antitumor drugs with natural DNA: proton NMR study of binding mode and kineticsJournal of Medicinal Chemistry, 1984